Ameritas Investment Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.2K | Sell |
22,894
-3,200
| -12% | -$5.72K | ﹤0.01% | 2383 |
|
|
2025
Q4 | $48.8K | Hold |
26,094
| – | – | ﹤0.01% | 2134 |
|
|
2025
Q3 | $33.4K | Hold |
26,094
| – | – | ﹤0.01% | 2424 |
|
|
2025
Q2 | $32.4K | Hold |
26,094
| – | – | ﹤0.01% | 2450 |
|
|
2025
Q1 | $30.8K | Hold |
26,094
| – | – | ﹤0.01% | 2369 |
|
|
2024
Q4 | $47.8K | Hold |
26,094
| – | – | ﹤0.01% | 2210 |
|
|
2024
Q3 | $44.4K | Hold |
26,094
| – | – | ﹤0.01% | 2264 |
|
|
2024
Q2 | $35.7K | Hold |
26,094
| – | – | ﹤0.01% | 2319 |
|
|
2024
Q1 | $97.9K | Hold |
26,094
| – | – | ﹤0.01% | 1758 |
|
|
2023
Q4 | $256K | Buy |
26,094
+1,049
| +4% | +$8.58K | 0.01% | 1118 |
|
|
2023
Q3 | $209K | Buy |
25,045
+4,229
| +20% | +$48.3K | 0.01% | 1144 |
|
|
2023
Q2 | $277K | Buy |
20,816
+925
| +5% | +$11.2K | 0.01% | 957 |
|
|
2023
Q1 | $230K | Buy |
19,891
+1,816
| +10% | +$18.1K | 0.01% | 1013 |
|
|
2022
Q4 | $205K | Buy |
18,075
+1,134
| +7% | +$9.77K | 0.01% | 1125 |
|
|
2022
Q3 | $98K | Hold |
16,941
| – | – | ﹤0.01% | 1501 |
|
|
2022
Q2 | $74K | Buy |
16,941
+2,033
| +14% | +$12.4K | ﹤0.01% | 1713 |
|
|
2022
Q1 | $136K | Hold |
14,908
| – | – | ﹤0.01% | 1435 |
|
|
2021
Q4 | $305K | Hold |
14,908
| – | – | 0.01% | 981 |
|
|
2021
Q3 | $381K | Sell |
14,908
-493
| -3% | -$14.6K | 0.01% | 866 |
|
|
2021
Q2 | $539K | Buy |
15,401
+590
| +4% | +$17.2K | 0.02% | 774 |
|
|
2021
Q1 | $493K | Hold |
14,811
| – | – | 0.02% | 788 |
|
|
2020
Q4 | $384K | Buy |
14,811
+593
| +4% | +$10.1K | 0.02% | 846 |
|
|
2020
Q3 | $140K | Buy |
14,218
+1,481
| +12% | +$8.53K | 0.01% | 1228 |
|
|
2020
Q2 | $44K | Hold |
12,737
| – | – | ﹤0.01% | 1914 |
|
|
2020
Q1 | $39K | Buy |
12,737
+1,428
| +13% | +$5.85K | ﹤0.01% | 1802 |
|
|
2019
Q4 | $58K | Hold |
11,309
| – | – | ﹤0.01% | 1834 |
|
|
2019
Q3 | $58K | Hold |
11,309
| – | – | ﹤0.01% | 1798 |
|
|
2019
Q2 | $68K | Hold |
11,309
| – | – | ﹤0.01% | 1732 |
|
|
2019
Q1 | $82K | Buy |
11,309
+1,200
| +12% | +$8.68K | ﹤0.01% | 1594 |
|
|
2018
Q4 | $75K | Buy |
10,109
+1,280
| +14% | +$8.11K | ﹤0.01% | 1576 |
|
|
2018
Q3 | $48K | Hold |
8,829
| – | – | ﹤0.01% | 2016 |
|
|
2018
Q2 | $31K | Hold |
8,829
| – | – | ﹤0.01% | 2264 |
|
|
2018
Q1 | $18K | Hold |
8,829
| – | – | ﹤0.01% | 2479 |
|
|
2017
Q4 | $23K | Buy |
8,829
+1,893
| +27% | +$6.63K | ﹤0.01% | 2367 |
|
|
2017
Q3 | $34K | Hold |
6,936
| – | – | ﹤0.01% | 2108 |
|
|
2017
Q2 | $25K | Hold |
6,936
| – | – | ﹤0.01% | 2340 |
|
|
2017
Q1 | $36K | Buy |
+6,936
| New | +$34K | ﹤0.01% | 2052 |
|
Other funds holding PACB
AIM
VCM
NAMA
Ameritas Investment Partners's PACB Position: Q1 2026 in Review
Ameritas Investment Partners reduced its Pacific Biosciences (PACB) stake by 12% in Q1 2026, selling an estimated $5.72K and leaving 22,894 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2383.
Ameritas Investment Partners first reported a position in PACB in Q1 2017 and has held it in 37 quarters since. The position peaked at $539K in Q2 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.
- Ameritas Investment Partners held 22,894 shares of Pacific Biosciences worth $30.2K as of Q1 2026.
- Ameritas Investment Partners sold 3,200 Pacific Biosciences shares in Q1 2026, an estimated $5.72K.
- Pacific Biosciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2383 holding.
- Ameritas Investment Partners first reported a position in Pacific Biosciences in Q1 2017 and has held it in 37 quarters since.
- Ameritas Investment Partners's Pacific Biosciences position peaked at $539K in Q2 2021.
- 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.